Abstract We describe a case of Actinomycetoma foot which presented to us after 3yrs of onset of symptoms.We have attempted a chemotherapeutic treatment regime and are reporting the healing changes that have taken place radiologically and macroscopically. A review of literature has been done of various treatment regimens used for Actinomycetoma foot and used and their practical applications in rural hospital.
Madura mycetoma is a chronic progressive granulomatous exogenous infection of skin, subcutaneous tissue, fascia, muscle, and occasionally the underlying bone and adjacent organs caused by heterogeneous infecting agents such as fungi, actinomycetes, and bacteria [1, 2] . It is more common in males, especially those in their third or fourth decade who work on the land. The clinical triad of subcutaneous nodule, sinuses, and discharge usually leads to diagnosis; the disease is commonly painless [3] . It is characterized by firm tumefaction of the affected site, with abscess, nodules, and sinuses that drain serosanguinous exudates containing filamentous granules.
Historically, the disease was recognized in 1842 by Gill while working in Madurai in India [4] . Carter [5] and Bidie [6] established the fungal etiology and named it mycetoma. The disease is endemic in the mycetoma belt between latitude 15 South and 30 North. Mycetomas are frequent in the tropical zones of Asia (India) [7] [8] [9] [10] [11] , Africa (Senegal, Mauritius, and Sudan) [4, 14, 15] and America (Mexico, Brazil, Venezuela) [16, 17] . Madurella mycetomatis and Streptomyces somaliensis predominate in tropical parts of Africa and Asia. Nocardia brasiliensis and Actinomadura madurae commonly cause mycetoma in Mexico and South America.
Mycetoma is predominantly a disease of men in rural areas, who work bare foot on land such as farmers and daily labourers. Poor hygiene, low socioeconomic status, and low nutrition are the suggested risk factors. The causative agent that exists as saprophytes usually gains entry into the subcutaneous tissue through abrasions or implantation [4, 6, 8, 18, 19] . Infection begins in the skin and subcutaneous tissue causing local popular or nodular swelling that tends to grow and rupture, forming communicating sinus tracts through which grains are discharged. Grains vary from 0.2 to 3.0 mm in diameter and can be black, white, yellow, red, and pink depending on the causative organism [6, 9] . Some sinuses heal with scarring while fresh sinuses appear elsewhere, leading to enlargement and disfigurement of the affected limb (Fig. 1) . Eventually destruction of the bone occurs when grains invade the cortical margins and replace the spongiosa [20] Two groups of mycetoma exist, eumycetoma caused by true fungi or mycetes and actinomycetoma caused by fungi-like aerobic bacteria from actinomycomysetes species.
The prevalence of actinomycetes is higher than that of eumycetes in South India, whereas the reverse is seen in North India [12, 13, [21] [22] [23] .
Diagnosis
In early stages, mycetoma should be differentiated from various benign soft tissue tumors and in late stages from osteomyelitis due to pyogenic organisms.
Culture using deep tissue samples is carried out for fungi, bacteria, and actinomycetes in Sabouraud's dextrose agar medium, blood agar, Lowenstein Jenson's medium, and brain heart infusion agar medium.
Radiological examination: Local area X-ray as well as CT scan give details with regards to extent of involvement. The radiological features can be divided into the following two stages:
Early: swelling of soft tissue, widening of the inter metatarsal spaces, periosteal reaction Late: osteolytic and osteoscelrotic changes, ragged cortex, crypts in the cortex (Fig. 2) . 
Management
In early lesions without bone involvement, surgical excision followed by chemotherapy as an adjunct is the best option available. In late lesions with bone involvement, chemotherapy is the first choice, which could be followed by surgical excision. Response to medical treatment is usually better in actinomycetoma than eumycetoma. Eumycetoma is difficult to treat using current therapies. Surgery in combination with azole treatment is the recommended regimen for small eumycetoma lesions in the extremities. Bone involvement complicates clinical management, leaving surgical amputation as the only treatment option.
The treatment of eumycetoma is a major challenge. Even with the use of newer drugs the response to treatment is poor [24] .
Current concept in the treatment of actinomycotic mycetoma is using a combination of the drugs [25] .
The regimen used and the monitoring guidelines are as follows [26] The choice of treatment in mycetoma depends most importantly on the causative organisms. One of the most common problems is that affected patients are farmers or other outdoor laborers who often lack education and economic resources to obtain prompt medical evaluation, resulting in a considerable delay in treatment. Even when early diagnosis is made, patients usually cannot afford the treatment. The final outcome is potentially severe functional impairment and even amputation of the affected limb. The pathogenesis of mycetoma is incompletely understood, but the Fig. 1 Improvement in skin changes in mycetoma after treatment for 3 months Fig. 2 Osteolytic changes in Madura mycetoma failure of active mobilization of an effective early phagocytic response has been cited as a possible reason for fungal survival for a sufficient time for grains to develop. Early diagnosis and prompt intervention with antimycotics and/or surgery may eliminate the need for aggressive surgical treatment and amputation [28] [29] [30] .
